Global Phosphate Binders Market Insights and Forecast to 2027

Phosphate binders are medications used to reduce the absorption of dietary phosphate; they are taken along with meals and snacks. They are frequently used in people with chronic kidney failure (CKF), who are less able to excrete phosphate, resulting in an elevated serum phosphate.These agents work by binding to phosphate in the GI tract, thereby making it unavailable to the body for absorption. Hence, these drugs are usually taken with meals to bind any phosphate that may be present in the ingested food.

Market Analysis and Insights: Global Phosphate Binders Market
The global Phosphate Binders market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.

Global Phosphate Binders Scope and Market Size
Phosphate Binders market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Phosphate Binders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Calcium Carbonate
Calcium Acetate
Other

Segment by Application
Hospital
Clinic
Other

By Company
Opko Health
Akebia Therapeutics
Sanofi
Baxter
Shire
Natco
Novartis
Amgen
Torii Pharmaceutical
Meda Pharmaceuticals
AMAG Pharmaceuticals
Vifor Pharma

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia